Stock VBV VBI VACCINES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus VBI Vaccines Inc. Toronto S.E.

Equities

VBV

CA91822J1030

Delayed Toronto S.E.
Other stock markets
 05:39:59 2018-03-23 pm EDT 		5-day change 1st Jan Change
4.82 CAD -5.12% Intraday chart for VBI Vaccines Inc. -7.66% -10.58%
May. 29 VBI Vaccines Inc. Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients CI
May. 22 VBI Vaccines Inc. Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients CI

Evolution of the average Target Price on VBI Vaccines Inc.

Price target over the last 5 years

History of analyst recommendation changes

b2cd5f717d0fa5da3ae6c93dd510f.XMVK7B0XLle1PPZbCdAF-60sOvHv9C4lBGAmnL-oULI.JpoPi1svaD7HdY4sfeg9mJV7YsablwNASBoW1P3mIMAeig-BLk9YHfMEkQ~f9fa5f18781d12b27b910f2818b2d31c

Analyst Recommendations on VBI Vaccines Inc.

Raymond James Cuts Price Target on VBI Vaccines to $6 From $60, Maintains Outperform Rating MT
Raymond James Adjusts VBI Vaccines Price Target to $6 From $9, Maintains Strong Buy Rating MT
Jefferies Analyst Starts VBI Vaccines at Buy, Adjusts Price Target to $6 From $7 MT
VBI VACCINES : Jefferies Starts VBI Vaccines at Buy With $7 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.787 USD
Average target price
5 USD
Spread / Average Target
+535.32%
High Price Target
5 USD
Spread / Highest target
+535.32%
Low Price Target
5 USD
Spread / Lowest Target
+535.32%

Consensus detail

Consensus revision (last 18 months)

Analysts covering VBI Vaccines Inc.

Raymond James
Jefferies & Co.

Ratings for VBI Vaccines Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VBIV Stock
  4. VBV Stock
  5. Consensus VBI Vaccines Inc.